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Vertebral Fracture (PROVE): study protocol for a
randomised controlled trial
Karen L Barker1,2*, Muhammad K Javaid1, Meredith Newman2, Catherine Minns Lowe2, Nigel Stallard3,
Helen Campbell4, Varsha Gandhi1 and Sallie Lamb1Abstract
Background: Osteoporosis and vertebral fracture can have a considerable impact on an individual’s quality of life.
There is increasing evidence that physiotherapy including manual techniques and exercise interventions may have
an important treatment role. This pragmatic randomised controlled trial will investigate the clinical and
cost-effectiveness of two different physiotherapy approaches for people with osteoporosis and vertebral fracture,
in comparison to usual care.
Methods/Design: Six hundred people with osteoporosis and a clinically diagnosed vertebral fracture will be
recruited and randomly allocated to one of three management strategies, usual care (control - A), an exercise-based
physiotherapy intervention (B) or a manual therapy-based physiotherapy intervention (C). Those in the usual care
arm will receive a single session of education and advice, those in the active treatment arms (B + C) will be offered
seven individual physiotherapy sessions over 12 weeks. The trial is designed as a prospective, adaptive
single-blinded randomised controlled trial. An interim analysis will be completed and if one intervention is clearly
superior the trial will be adapted at this point to continue with just one intervention and the control. The primary
outcomes are quality of life measured by the disease specific QUALLEFO 41 and the Timed Loaded Standing test
measured at 1 year.
Discussion: There are a variety of different physiotherapy packages used to treat patients with osteoporotic
vertebral fracture. At present, the indication for each different therapy is not well defined, and the effectiveness of
different modalities is unknown.
Trial registration: Reference number ISRCTN49117867.
Keywords: Randomised controlled trial, Osteoporosis, Rehabilitation, Vertebral fractureBackground
Each year 25,000 people in the UK have vertebral frac-
tures related to their osteoporosis and many are referred
for physiotherapy to help them recover after their frac-
ture. Osteoporosis and vertebral fracture can have a con-
siderable impact on an individual’s health-related quality
of life (QoL) due to pain, limitations in activity, social* Correspondence: Karen.Barker@ouh.nhs.uk
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reproduction in any medium, provided the orparticipation and altered mood [1,2]. Vertebral fractures
are closely related to increased thoracic kyphosis, which,
along with a loss of lumbar lordosis, is linked to in-
creased spinal loading and back extensor muscle weak-
ness. This can lead to an increased risk of further
fracture [3,4]. Hyperkyphotic posture is also associated
with increased back pain and balance disturbance with a
subsequent increased risk of falls and fractures as a re-
sult of falling [5,6].
Physiotherapy includes a variety of treatment options,
such as exercise programmes or ‘hands on’ treatments
such as massage and mobilisations. There is increasing
evidence that physiotherapy interventions that addresstd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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role in improving QoL and reducing the fracture risk in
people with osteoporotic vertebral fractures. However,
we do not know which type of physiotherapy is most
helpful, the cost of treatment to the National Health Ser-
vice (NHS), or what patients think of their treatment.
Evidence for manual therapies
Manual mobilisation
Traditionally, physiotherapists use manual mobilisation
in the management of back pain. However, evidence for
the effectiveness and safety of manual mobilisations in
the management of thoracic hyperkyphosis in elderly
people is limited. Some physiotherapy guidelines caution
against using spinal mobilisation in individuals with
osteoporosis. High velocity spinal manipulation tech-
niques are contraindicated [7] and concerns about the
use of low velocity spinal mobilisation techniques have
been expressed. However, recent practice surveys, case
reports and two randomised controlled trials (RCTs)
suggest these techniques can be used safely [8-11]. No
serious adverse events were reported in either RCT of
low velocity spinal mobilisation. Both RCTs have small
sample sizes, short-term follow-up and have tested a
combined treatment protocol of exercise and manual
therapy including postural taping. These factors make it
difficult to draw confident inference about the safety and
effectiveness of the various treatment methods [8,9].
Postural taping
Postural taping uses tape applied to the skin to provide
increased proprioceptive feedback about postural align-
ment, improve thoracic extension, reduce pain and fa-
cilitate postural muscle activity and balance [6,8,9,12].
Evidence for exercise interventions
A number of systematic reviews and meta-analyses re-
port the positive effects of exercise on bone mineral
density (BMD), muscle strength, QoL and falls and frac-
tures in men and women with osteoporosis or low BMD
[13-16]. It is known that an osteoporotic vertebral frac-
ture leads to axial posture deformity which can increase
both the fear and the actual risk of falling. Strategies to
address falling are an important component of any treat-
ment programme for this patient group [5,6,17,18]. A
number of RCTs have found that a combined balance
and progressive strength training programme produced
the best results in terms of maintaining leg strength, bal-
ance, BMD and physical function compared to balance
or strength training alone [14,19-21].
RCTs of exercise interventions in people with vertebral
osteoporosis also report benefits of reduced pain and
improved QoL, strength and balance [22-28]. Interven-
tions range from simple back extension exercises to avariety of general weight-bearing exercise, balance activ-
ities, stretches and combined upper limb, trunk and
lower limb strengthening. The interventions were deliv-
ered in a class format [26-28], as a home programme
[23,25] or as a combination of physiotherapist-led along
with home exercise programmes [28]. There was no evi-
dence that any of these delivery options was superior to
another.
Overall, there is some evidence that both manual ther-
apy and exercise interventions can be beneficial for this
patient group. A limited number of studies [8-12] pro-
vide strong support for the use of manual therapies but
these are inadequately powered. There is some higher
quality evidence available to support exercise prescrip-
tion for individuals with osteoporosis but only a few
studies examine exercise in osteoporotic populations
with vertebral fracture [22,24,28]. Of these, only a small
number combine weight-bearing, strength and balance
activities and, to date, none have included men. Whether
exercise therapy is more effective than manual therapy is
not known and further information is needed about the
longer term outcomes of either intervention.
Objectives
This paper describes the trial protocol for a large, prag-
matic RCT to assess the effects of a physiotherapy inter-
vention based on exercise or manual therapy compared
to usual care for people with osteoporosis and a clinic-
ally diagnosed vertebral fracture.
The secondary objectives are: 1) to compare the effects
of manual therapy with exercise therapy; 2) to investi-
gate the acceptability and adherence to the physiothe-
rapy programmes for both patients and therapists; 3) to
conduct a parallel health economic analysis to assess the
cost effectiveness of the different treatment strategies
from an NHS, Social Services and patients’ perspective;
and 4) to conduct a nested qualitative study to explore
the experiences and views of people with osteoporo-
sis and vertebral fracture regarding their treatment,
their perceptions regarding the appropriateness and ac-
ceptability of the interventions and to explore the fac-
tors influencing their adherence to the intervention
programmes.
Methods/Design
Trial design
The trial will be a prospective, multi-centre assessor-
blinded, three-arm RCT with a nested qualitative study and
an adaptive design. Patients will be randomised between
three arms: usual care (control) group (A), manual therapy
(B) and exercise therapy (C). Those in the usual care arm
will receive a single session of education and advice, and
those in the active treatment arms (B +C) will be offered
up to seven individual physiotherapy sessions over 12
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(week 0), 4 months and 12 months, with postal question-
naires about QoL administered at 6 and 9 months. An in-
terim analysis will be conducted once 75 participants are
recruited to each arm and have completed their 4 month
follow-up. Following this interim analysis the study may be
adapted. If both intervention arms are sufficiently promis-
ing and sufficiently similar the study will not be adapted
and recruitment will continue into both intervention arms.
If one arm, manual therapy or exercise therapy, is not suffi-
ciently promising relative to control or sufficiently similar
to the other intervention arm, this arm will be dropped
from the study and the study will be adapted to continue as
a two arm RCT with participants randomised between the
control and remaining intervention arm. If neither arm is
sufficiently superior to the usual care arm the trial will be
stopped.
The protocol conforms to CONSORT guidelines for
non-pharmacological studies [29] (Figure 1).Ethics approval
The study protocol was approved by South Central Re-
search Ethics Committee [Reference 12/SC/0411]. Oxford
University is the sponsor. The trial is registered with the
International Standard Randomised Controlled Trials data-
base ISRCTN reference number 49117867.Trial status
Recruitment started in November 2013.Recruitment via 10 ce
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Figure 1 Study flow chart.Participants
Six hundred patients will be recruited from 10 or more
centres across the UK. Men and women with osteopor-
osis who have had a least one symptomatic vertebral
fracture will be eligible for inclusion if they meet the fol-
lowing criteria.Inclusion criteria
1. Willing and able to give informed consent for
participation in the study.
2. Diagnosis of primary osteoporosis confirmed
by radiograph or DEXA scan (−2.5 SD below
young adult mean) at lowest lumbar level.
3. At least one previous vertebral fracture.
4. Men and women aged 18 years or older.
5. Female participants to be postmenopausal;
that is, no period in the last 2 years.
6. All should be able to walk at least 10 metres
independently with or without an aid and be
able to understand and participate in a
physiotherapy programme.Exclusion criteria
Individuals may not enter the study if they have any con-
dition which might make participating in the physiother-
apy or exercise regimes unsafe or confound results.
People with the following will therefore be excluded:ntres n = 600
lity Consent, 
sment
Manual Therapy 
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(MT) 
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disease.
2. Significant psychiatric or neurological conditions.
3. Bone loss secondary to other metabolic bone
disorders or disease will be excluded (for example,
rheumatoid arthritis, cancer, osteomalacia).
4. Individuals whose primary problem is back pain
with pain radiating into the lower limb.
5. Individuals who have had a vertebroplasty, facet
joint injection or any physical therapy (for example,
chiropractic, osteopathy or physiotherapy treatment)
for back pain in the previous 12 weeks. However,
individuals who have had back pain and any of these
treatments prior to this period will be eligible.
Procedures
Recruitment
Potential participants will be approached by clinicians
during their routine clinic attendance. Clinicians treating
potentially eligible participants for the trial will intro-
duce the study, hand out an invitation pack and obtain
consent for a Physiotherapy Rehabilitation for Osteopor-
otic Vertebral Fracture (PROVE) trained researcher to
make contact 3 to 7 days later. Participants consenting
to enrol in the study will undergo a baseline assessment;
following this the assessor will telephone the independ-
ent randomisation centre.
Randomisation, blinding and allocation concealment
Randomisation will be performed by an independent
statistician and implemented by the central telephone
registration and randomisation service at the Warwick
Clinical Trials Unit. Staff will register patients after
confirming eligibility, consent and baseline assessment,
thus ensuring allocation concealment.
Baseline and follow-up assessments will be per-
formed by a blinded research physiotherapist. These
staff will not be involved in delivering the treatment
interventions. All data will be entered by a dataTable 1 Summary of outcomes and assessment schedule
Tests Administered by We
Functional Co-morbidities Index Self
QUALEFFO 41 Self
EQ-5D-5 L Self
Physical Activity Scale for the Elderly Self
Timed Load Standing Assessing therapist
Flexicurve ruler Assessing therapist
The Short Performance Physical Battery Assessing therapist
The Functional Reach test Assessing therapist
6 minute walk test Assessing therapist
10 point visual analogue scale Selfentry assistant to ensure the research physiothera-
pists remain blind to treatment assignment. All
study personnel involved in data entry, management
and analysis will be blinded until the final analysis is
complete. By virtue of the design it is not possible
to blind the participants or the physiotherapists pro-
viding the treatment interventions [30].
After randomisation the Clinical Trials Unit will in-
form the research therapist at each site of a participant’s
treatment allocation, and they will liaise with appropriate
clinical staff to provide the correct intervention.
Baseline assessment
After participants have been assessed for eligibility and con-
sent has been gained, baseline assessment will be carried
out. Questionnaires and physical assessment will be com-
pleted (both participant and assessor will be unaware of al-
location at this appointment). The baseline measures are
summarised in Table 1.
Outcome measures
There are two primary outcomes for this study: one
measure of QoL and one measure of physical function.
1. The QUALEFFO 41 is a disease-specific measure
of health related QoL applicable to patients
with established vertebral osteoporosis. It is a
self-administered questionnaire that provides
scores on five domains; pain, physical function,
social function, general health perception,
mental performance, and a total score. It is
validated and reliable and has been shown to be
responsive in clinical trials of physiotherapy
treatment [31]
2. The Timed Loaded Standing (TLS) test assesses
back extensor muscle endurance [32]. Based
upon previous literature [9], a 2.6 second change
in the TLS test would be clinically significant for
a change between the groups.ek 0 Month 4 Month 6 Month 9 Month 12
√
√ √ By post By post √
√ √ By post By post √
√ √ By post By post √
√ √ √
√ √ √
√ √ √
√ √ √
√ √ √
√ √ √
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a treatment effect in both the QUALEFFO 41 and TLS
as described more fully below.
Secondary outcomes
There are a number of outcomes included seeking to
assess a number of different aspects of symptoms,
function and activity. We will be piloting the pack-
age, and if the burden of measurement is too great,
some measures will be dropped and the protocol
amended.
The Functional Co-morbidities Index will be com-
pleted as other diseases are likely to be present in this
older population which might affect physical outcomes
[33].
Spinal curvature and flexed posture will be de-
scribed by recording height (cm) and thoracic ky-
phosis. Thoracic kyphosis will be measured using a
flexicurve ruler with the patient in a standing pos-
ition to calculate an index and angle of kyphosis
[34].
Other outcomes include measures of balance, mobility
and physical activity. Each test is reliable and valid, has
been used with older, community dwelling adults and
shown to be responsive in previous rehabilitation
studies.
 The Short Performance Physical Battery will be used
to assess lower extremity physical function [35].
Poor performance is predictive of future disability,
hospitalisation and care needs.
 The Functional Reach Test will be used to
specifically evaluate standing balance and to act as a
predictor of falls risk [36].
 A 6 minute walk at self-selected speed over a 30
metre course will be used to measure exercise en-
durance; an important parameter of functional, com-
munity mobility [37].
 The Physical Activity Scale for the Elderly is a short,
self-administered questionnaire to assess activity in
the past week [38].
 The EuroQol EQ-5D-5 L is a short, generic measure
of QoL and will be completed to facilitate the assess-
ment of cost-effectiveness and also to give a com-
parison with other clinical conditions [39].
 Participants will be asked to specifically rate back
pain on activity and at rest using a 10 point visual
analogue scale.
 Information about fractures and falls will be
collected using a standardised definition and a
prospective participant completed event calendar.
These will be mailed to participants monthly during
the year of the study and participants will be
telephoned by the trial co-ordinator to promoteadherence and to check this information is captured
precisely [40].
Follow-up data collection
Follow-up data collection will be by face-to-face clinical
assessment at 4 and 12 months.
Interventions
Treatments are standardised, but it is considered im-
portant to allow therapists to personalise treatments as
appropriate. For example, therapists will be able to omit
or adjust the intensity of any technique or exercise to re-
flect an individual participant’s capabilities and their
progress.
Best practice usual care
Currently, relatively few patients are referred for formal
physiotherapy for an osteoporotic vertebral fracture.
Therefore, a single education session will form the usual
care arm. The education will be general advice about
osteoporosis, and lifestyle choices to promote bone
health in line with the information available from the
National Osteoporosis Society.
Active interventions
Participants in each active intervention group will be of-
fered up to seven individual physiotherapy sessions over
12 weeks. A 12-week programme was chosen to allow
time to progress the treatment intensity and achieve
gains in strength and mobility [9,25]. This pragmatic re-
gime allocates equivalent physiotherapist contact time to
participants in each intervention group and broadly re-
flects current outpatient physiotherapy resources within
the NHS. Alongside individual sessions, participants in
each intervention group will receive education about
osteoporosis and general advice about exercise.
Manual therapy intervention Manual therapies will in-
clude low velocity spinal mobilisation performed without
discomfort [8-10] and soft tissue mobilisation to erector
spinae, rhomboids and upper trapezius muscles [9]. Pos-
tural taping will be used once weekly and, if tolerated, it
will be worn continuously for 3 days for the first 4
weeks. It will be applied to create gentle skin traction
and sensory feedback about posture when the individual
moves into flexion [8,9,12]. The home programme will
be a passive stretch that promotes thoracic extension for
15 minutes per day [4].
Exercise intervention The exercise programme will in-
clude active stretches, progressive balance and strength
training and low to moderate intensity weight-bearing
aerobic activity (for example, walking). Exercises will be
Barker et al. Trials 2014, 15:22 Page 6 of 11
http://www.trialsjournal.com/content/15/1/22practised in the treatment sessions and continued in the
home programme. The Rating of Perceived Exertion
scale will be used to set the initial load of strength exer-
cises and walking duration at a self-perceived moderate
level of effort, to facilitate monitoring and allow struc-
tured progression. Participants will be asked to include
short sessions of exercise within daily life, aiming to
achieve a total of 60 minutes of exercise per day, three
to five times a week depending on ability (for example, a
30 minute walk along with 30 minutes of stretches, bal-
ance and strengthening exercises [28]). Stretches will
promote spinal extension, shoulder flexion, hip exten-
sion and ankle dorsiflexion [28]. Specific trunk extension
and lumbar stabilisation exercises will be included
[4,22,23]. There will also be upper body and lower body
strengthening exercises [22,28] and specific balance ex-
ercises such as single leg standing [21,26]. Wherever
possible exercises will use body weight and gravity to
provide resistance and balance related activities to the
programme (for example, sit to stand will be encouragedFlowch
Research Clinic 
eligibility, conse
Randomisa
Usual care controls Manual
Assessment & advice session
Treatme
Treatme
Treatme
Treatme
Assessmen
4/
12
Treatme
Treatme
Figure 2 Flowchart of interventions. 4/12 f/u, 4- and 12-month follow-uto increase proprioceptive input [20]). We will use a
series of educational and motivational strategies to foster
compliance: clinician-patient goal setting, the provision
of an exercise diary with a log sheet to record sessions,
along with a scheduled telephone call to support prac-
tice [41]. Completion of home practice will be moni-
tored through exercise diaries and compliance will be
defined as 60% completion. Participants undergoing the
interventions will be encouraged to continue their home
exercises at the end of the active phase of the trial.
Figure 2 provides an overview of the interventions in
each trial arm.
Adherence
Compliance with treatment will be defined as attending
at least four treatment sessions. The number of physio-
therapy visits and content of treatment sessions will be
recorded using both therapist-completed treatment logs
and patient exercise and participation diaries. Compli-
ance of the physiotherapists to the treatment protocolart of Interventions
Appointment, confirm 
nt baseline assessment
tion and Referral
 Therapy Exercise Therapy
Assessment and advice
nt session 5
nt session 3
nt session 2
nt session 1
t and advice
12 f/u
/12 f/u
Exercise session 2
Exercise session 3
Exercise session 5
Exercise session 6
nt session 4
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Exercise session 4
Exercise session 1
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ment logs and by site visits.
Quality monitoring
There will be initial training provided to all PROVE trial
assessors and clinicians involved in delivering the inter-
vention at all sites. Once the training has been com-
pleted the following procedures are in place to promote
consistency and high quality trial procedures across all
sites:
 A member of the PROVE team will observe each
assessor perform one of their first assessments to
ensure they take place as per protocol. Repeat visits
will be undertaken should any concerns arise until
reliable and valid assessments occur.
 Within 2 weeks copies of all assessment forms will
be sent to the trial co-ordinator for checking to
identify any issues concerning missing data or poorly
completed forms. Any issues or concerns will be dis-
cussed with individual assessors.
 A member of the PROVE team will observe each
clinician perform one of their first treatments to
ensure all treatments adhere to the protocol.
 Clinicians will be asked to complete a treatment log
for each attendance, providing an approximate
estimation of the time spent on key intervention
components and detailing and explaining any
deviations from the protocol.
 A member of the PROVE team will check each site’s
trial master file and meet with researchers and
clinicians from each site on an annual basis (or
more frequently should this be necessary). During
these meetings, feedback will be sought regarding
trial procedures and the perceived acceptability of
the intervention. Feedback will be documented and
a copy of the minutes of the meeting will be
returned to each site.
Health economics
An economic evaluation is designed as an integral part of
the trial and will take the form of a cost-utility analysis
conducted from an NHS and Social Services perspective.
Health outcomes will be expressed as quality-adjusted life
years (QALYs) by combining survival and EuroQol EQ-5D
data collected from each participant to 12 months. The
cost to the health service of providing current practice
and each type of physiotherapy intervention will be esti-
mated during the trial, and participants will provide infor-
mation to 12 months on healthcare contacts (for example,
visits to the General Practitioner, outpatient clinics, and
inpatient admissions). Care provided by Social Services
will be documented as well as any out of pocket costs in-
curred by participants.Qualitative study
The qualitative study will help to provide a picture of
the issues facing participants with osteoporosis and ver-
tebral fracture who participate in the treatment interven-
tions arms of the study. Semi-structured interviews will
be conducted by a researcher experienced in the design,
collection and analysis of qualitative data. Specific topics
covered will be exercising with osteoporosis (including
adherence issues), and participant experience of the
PROVE trial. We will interview enough participants to
ensure we are confident that theoretical sufficiency will
be achieved [42]. Purposive sampling will be used to
achieve a sample which includes female and male pa-
tients, thoracic and lumbar single/multiple vertebral
fracture patients and patients of varying activity levels.
Fracture site, number of fractures and activity levels are
known to influence outcome and, since the majority of
research regarding osteoporotic patients’ QoL has pre-
viously been undertaken with women, it is considered
important to capture the views of male participants
within the current study.
Interviews will be conducted either in the hospital or
participants homes following the completion of the
intervention and the 4-month follow-up appointment.
The development of the interview schedule will be itera-
tive and the questions asked may develop and change as
the interviews are conducted and analysed [43]. All in-
terviews will be digitally recorded and fully transcribed
for analysis. Analysis will utilise Smith’s experiential ap-
proach of Interpretative Phenomenological Analysis. A
feature of Interpretative Phenomenological Analysis is
that the first steps of analysis begin early in the research
process with initial data coding and is simultaneous to
data collection. Initial analysis of each interview will be
carried out as soon after its completion as possible fol-
lowing the guidelines set out by Smith [43].
One in five of the interviews will be coded indepen-
dently by a second member of the research team with
experience of qualitative research to provide a different
perspective on the coding. The research team will dis-
cuss the development of themes as the research pro-
gresses, once again with the aim of providing a different
perspective and enhancing the development of themes.
Data and statistical analysis
Interim analysis decision rules
The decision to adapt the trial following the interim ana-
lysis and whether to drop one of the treatment arms, or
to continue, will be made by the Trial Steering Commit-
tee based upon the recommendations of the independ-
ent data monitoring committee (IDMC). The IDMC will
base their decision on the data from the interim analysis,
using the rules below, together with data on adverse
events, falls and further fracture history. An interim
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data are available for 75 patients per treatment arm. The
aim of this interim analysis is to terminate either the
manual therapy or exercise therapy arm if it appears to
be poorly performing relative to the other intervention
or to the control, or to terminate the trial completely if
both intervention arms appear to be performing poorly
relative to the control.
Although the integrity of the trial in terms of type I
error control does not require pre-specification of the
decision rule to be used at the interim analysis, as a
guideline for the IDMC the interim analysis decision
rule will be based on comparison of the estimated mean
change from baseline in the QUALEFFO score for each
of the three study arms as follows:
a) If the mean change from baseline of the QUALEFFO
score for an intervention arm is not more than 0.5
points greater than that for the control arm, that
intervention arm will be dropped from the study.
Note that under this rule both intervention arms
might be dropped, in which case the study would
stop due to futility.
b) If the mean change from baseline of the QUALEFFO
score for one intervention group is more than 2
points higher than for the other group, the
intervention with the lower mean change from
baseline will be dropped from the study.
Sample size
The initial sample size calculation is based on a trad-
itional approach to a three-arm trial. We wish to detect
a standardised effect of 0.4 in the QUALEFFO; at 80%
power and an alpha of 0.05 we would require 180 to 200
participants in each arm or 540 to 600 people (we will
use 600 people as the upper limit).
A simulation study was conducted to estimate the
power of the study assuming the interim decision rules
above were used. The sample size for the interim ana-
lysis was chosen to be 75 per arm. This ensures that the
power is high while the probability of continuing with
an ineffective treatment is sufficiently low. If the true
(unknown) treatment effect for an intervention is equal
to the control, the probability of dropping that interven-
tion at the interim analysis is approximately 73%. If nei-
ther intervention is truly superior to the control, the
probability of stopping the entire study at the interim
analysis is approximately 60%. Based on this interim
analysis sample size the standard error of the estimated
difference between the intervention arms and the con-
trol arm at the interim analysis will be 0.82.
In the adaptive design of the type proposed, the power
of the study may be defined as the probability, given a
truly effective intervention, that the intervention remainsin the trial at the interim analysis and leads to a signifi-
cant result in comparison to the control in the final ana-
lysis. The specified sample size gives 94% power if the
better of the two intervention arms has a true standar-
dised treatment effect of 0.4.
Statistical analysis
We will report according to CONSORT standards.
Regression models will be used to estimate the treat-
ment effects (with 95% confidence intervals) and will be
adjusted for important covariates (prior fracture history
and age). The final statistical analysis will include data
from patients from the control arm and intervention
arm(s) continuing beyond the interim analysis from both
the first and second stages of the trial. The analysis
needs to allow for the adaptation made at the interim
analysis in order to ensure that the probability of a type
I error (false positive result) is controlled. It is proposed
to use the analysis method described by Bretz and col-
leagues [44], applying a Dunnett correction to the com-
parisons between the intervention arms and the control
arm at the first stage and at the second stage unless an
intervention arm is dropped.
Complier-average causal effect will be estimated to as-
sess the impact of adherence on the effect of the
interventions.
Health economics
Mean (and standard deviation) per patient costs and
QALYs for the control and for the intervention(s) se-
lected for the full 12-month evaluation through the
adaptive trial design will be computed. Modelling will be
used to extrapolate clinical events, costs and QALYs be-
yond the 12-month trial follow-up. Incremental analyses
will be performed, with differences in costs and QALYs
between alternatives calculated, and an incremental cost
(s) per QALY gained will be estimated. Uncertainty
around the cost per QALY value(s) will be quantified
using non-parametric bootstrapping. Results from the
economic evaluation will identify the intervention with
the greatest probability of being cost-effective given the
NHS’s willingness to pay for additional health gain.
Timeline
The trial is funded to run over a period of 51 months
and commenced in January 2013. The final follow-up
visit for the final participant is projected to be completed
by the end of month 42 (that is, by June 2016). Data
analysis, economic analysis and report writing will be
from month 45 onwards.
Discussion
Osteoporosis and vertebral fracture have a considerable
impact on an individual’s health-related QoL due to
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altered mood. The need to develop effective treatment
approaches for osteoporosis and to decrease the health
burden of associated vertebral fractures is an important
clinical and research objective. This pragmatic RCT will
provide high quality evidence of the longer term clinical
and cost effectiveness of two physiotherapy-based inter-
ventions. Overall, there is evidence of proof of concept
that both manual therapy and exercise interventions can
be beneficial for this patient group. However, currently
there are questions about compliance with exercise pro-
grammes and whether a positive effect can be seen at
levels of intervention intensity that are deliverable within
current NHS resources. This trial design allocates
equivalent physiotherapist contact time to participants
in each intervention group and broadly reflects current
outpatient physiotherapy resources within the NHS
which should assist with delivery and generalisability of
any findings.
Our study offers a novel approach in using an adaptive
trial design to assess the efficacy of a rehabilitation inter-
vention. At the outset the plan is to conduct a multi-
centred, three-arm RCT with blinded assessments. The
justification for using an adaptive design is that this is a
new and emerging area of clinical practice. Instead of of-
fering a “black box” of combined manual and exercise
therapies, we have a chance to estimate the effects of these
treatment strategies in isolation. Each is indicated for
adults with symptomatic osteoporotic vertebral fracture.
There are some reported concerns with the efficacy and
safety of spinal mobilisation [10,11], thus there is merit in
testing manual therapy in isolation against an exercise-
based intervention. Additionally, spinal mobilisations are
the most expensive physiotherapy modalities to deliver as
they cannot be self-administered, and require individual
sessions. Using an adaptive design allows the trial to be
adapted to a two-arm trial, with resulting increased power,
should one of the intervention arms be assessed as inef-
fective at interim analysis. If neither intervention shows
benefit, the trial would be stopped early using futility
rules. We believe that this adaptive design has merits over
testing a multi-modal programme of combined exercise
and manual treatments where it is difficult to evaluate the
efficacy of individual components. There would also be
significant concerns about the safety and cost of some as-
pects of the multi-modal programme, that make isolating
the interventions an attractive option in terms of new
knowledge gained.
Importantly, the pragmatic approach offered in this
trial allows programmes in both intervention arms to be
individualised with regard to the content and intensity
level of the exercise or manual therapy technique. This
makes it less artificial than many RCT intervention de-
signs and thus much closer to normal clinical practice.Our study is the first large-scale RCT to investigate the
effect of different physiotherapy management strategies –
exercise or manual therapy intervention for patients with
osteoporosis and vertebral fracture. We plan to recruit
600 patients to the trial. Even if the adaptive design and
interim analysis rules proved that neither intervention
were effective and the trial was stopped on the grounds of
futility, it will still be the largest RCT conducted of physio-
therapy and osteoporosis. Strengths of the study design
are the pragmatic nature of treatment delivery by prac-
ticing physiotherapists in NHS physiotherapy clinics
across the UK, as well as the reproducibility of both the
physiotherapy intervention programmes. These features
will improve the ability to translate the findings into a
standard practice and enable future delivery of the inter-
vention to be given within existing NHS resource levels
and the constraints of a publically funded health system.
In addition to this paper, updated versions of the protocol
if amended throughout the trial will be available on the trial
website (http://www.ndorms.ox.ac.uk/clinicaltrials/prove)
and will follow SPIRIT 2013 guidelines [45].
Trial status
The first patient was randomised to the trial in September
2013. Recruitment for the study is ongoing.
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